Collplant plans clinical trials for dermal filler and advances regenerative implants
Source: SeekingAlpha
2025-03-26 19:59:08 ET
More on CollPlant Biotechnologies
- CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on CollPlant Biotechnologies
- Historical earnings data for CollPlant Biotechnologies
- Financial information for CollPlant Biotechnologies
Read the full article on Seeking Alpha
For further details see:
Collplant plans clinical trials for dermal filler and advances regenerative implants
CollPlant Holdings Ltd.
NASDAQ: CLGN
CLGN Trading
-1.9% G/L:
$0.6082 Last:
18,795 Volume:
$0.6001 Open:
CLGN Latest News
CLGN Stock Data
$8,706,044
9,102,937
N/A
15
N/A
Biotechnology & Life Sciences
Healthcare
IL
Rehovot
